D. E. Shaw & Co., Inc. Kala Pharmaceuticals, Inc. Put Options Transaction History
D. E. Shaw & Co., Inc.
- $122 Billion
- Q4 2024
Put Options
0 transactions
Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
---|
About Kala Pharmaceuticals, Inc.
- Ticker KALA
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,464,160
- Market Cap $5.07M
- Description
- Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...